A Look at the Different Depression and Anxiety Medications

Home
>
Depression
>
A Look at the Different Depression and Anxiety Medications

A Look at the Different Depression and Anxiety Medications

While it may be easy to recite the various brand names and generalize their benefits enough to know they put us (or are supposed to put us) in a better mood, for lack of a better term, the drugs themselves can all be categorized individually, each working in a slightly different way.

The following is a list and very brief description, by category, of depression and anxiety medications currently prescribed by physicians.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs, which are fairly new to the arsenal of depression and anxiety medications, have gained immense popularity among prescribing psychiatrists within the past 10 years. They are usually prescribed during the early stages of depression, if a person has sought help and behavioral and/or psychotherapy has not proven effective enough. With appropriate dosage, SSRIs can "catch" depression before it becomes severe. Although they do not work for 20% to 40% of people who try them, their ability to work for people with minor (and even major) depressive illnesses makes them attractive enough to prescribing psychiatrists to try them first before moving on to more serious depression and anxiety medications and methods, if need be. SSRIs work on serotonin, one of the brain's three neurotransmitters.

SSRIs Brand name (chemical name)

Celexa (citalopram), Lexapro (escitalopram oxalate), Luvox (fluvoxamine), Paxil (paroxetine), Prozac (fluoxetine), Zoloft (sertraline)

Monoamine Oxidase Inhibitors (MOAIs)

MAOIs are the type of depression and anxiety medications that work for people who are mildly depressed, develop mild depression over a long period of time, are overly sensitive to their environment, or who are easily able to emerge from periods of depression. People who demonstrate an excess of a particular activity (ie, overeating, oversleeping, emotional overreaction) as compensation with stress can benefit from MAOIs, which work on the three neurotransmitters (called monoamines) found in the brain: norepinephrine, serotonin, and dopamine. These are usually only prescribed when a person hasn't responded to any of the other types of depression and anxiety medications.

A strict diet must be followed if taking an MAOI, because in conjunction with certain foods, the body can react with elevated blood pressure, headaches, fluctuating blood sugar (for people with diabetes), and in more severe cases, brain hemorrhage. Because of these risks, MAOIs were taken off the American market for a while, but were reintroduced for patients who haven't had luck with any other depression and anxiety medications.

MAOIs Brand name (chemical name)

Nardil (phenelzine), Parnate (tranylcypromine)

Tricyclic Antidepressants (TCAs)

Tricyclics have been available longer than any other depression and anxiety medications. In 1958, the first tricyclic, imipramine (Tofranil), was released to help combat major depression, and physicians saw a 70% positive response within their patients. Previously the only treatments for severely depressed patients were amphetamines and electroshock therapy. TCAs increase the brain's supply of serotonin and norepinephrine, two of the brain's three neurotransmitters, but it also affects some of the brain's other nerve impulses as well, and this allows for more side effects.

Severely depressed and/or hospitalized patients see the most benefit from taking TCAs because of its sedative effect. In the past, patients were usually prescribed tricyclics before anything else, but with the movement of psychiatrists (and patients!) toward heading off depression before it becomes severe and/or chronic, TCAs are now usually only prescribed if the other types of depression and anxiety medications don't work.

TCAs Brand name (chemical name)

Adapin (doxepin), Anafranil (clomipramine) , Elavil (amitriptyline), Endep (amitriptyline), Ludiomil (maprotiline), Norpramin (desipramine) , Pamelor (nortryptyline), Pertofrane (desipramine), Sinequan (doxepin), Surmontil (trimipramine), Tofranil (imipramine), Vivactil (protriptyline)

Non-specified or "Other" depression and anxiety medications Because their chemical make-ups do not fit into any of the other categories, the following list of depression and anxiety medications can only be termed as "other." Wellbutrin, Desyrel, Remeron, and Effexor are prescribed most. Each of the four drugs affects at least one of the brain's three neurotransmitters (norepinephrine, serotonin, dopamine), and as a result, each has its own particular set of side effects. As a result, psychiatrists are much more likely to prescribe one of the other types of depression and anxiety medications (SSRIs, MAOIs, TCAs) before switching to one of these. In some instances, a patient's regimen is augmented by combining an SSRI or TCA with an"other" depression and anxiety medications, but because of an MAOI's particular chemical make-up and dietary requirements, it is prescribed alone.

Brand names (chemical names) of Non-specified depression and anxiety medications

Buspar (buspirone), Cymbalta (duloxetine), Desyrel (trazodone) , Effexor (venlafaxine), Edronax, Vestra (reboxetine), Remeron (mirtazapine), Serzone (nefazodone), Wellbutrin (bupropion).

In August of 2004, the FDA approved the investigational drug Cymbaltaâ?¢ (duloxetine HCl), which demonstrated rapid relief of anxiety symptoms associated with depression that was sustained for the length of the study period, according to new data published in the journal Depression and Anxiety. In clinical studies, researchers attribute the medication's effect on a broad spectrum of depression symptoms, which include emotional and painful physical symptoms as well as anxiety, to its dual reuptake inhibition of both serotonin and norepinephrine.

Learn more about treating depression at http://www.e-mentalhealth.com

Charles E. Donovan

Author

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

In The News:

R&D Trends: Depression - Clinical attrition driven by mature market conditions
MarketWatch (press release)
Several drugs have progressed through the pipeline for depression in recent years, including Pristiq (desvenlafaxine; Pfizer), Oleptro (trazodone extended release; Labopharm), and Viibryd (Forest) in the US, and Valdoxan (agomelatine; Servier/Novartis) ...

and more »

Globe and Mail
Cheeseburger blues: High-fat foods may be making us depressed
Vancouver Sun
Fatty "comfort" foods might actually make people depressed, new Canadian research suggests. Universite de Montreal researchers are reporting that high-fat diets increase anxiety and depressive-like behaviours in mice — a finding that a leading ...
Cheeseburger blues: could high-fat foods be making us depressed?Ottawa Citizen
Comfort foods can lead to depression, study findsGlobe and Mail
A Heart Made of Face Parts; The Eating Depression Cycle ExplainedThe Atlantic Wire
Science Codex -Irish Health
all 52 news articles »

IMF Chief: World Facing Possibly Worst Economic Insecurity Since Great Depression
Wall Street Journal
"Your generation is facing probably the worst economic insecurity in decades, possibly ever since the Great Depression," IMF Managing Director Christine Lagarde said in her commencement speech to the John F. Kennedy School of Government graduates.

and more »

BigPond News
'Cheerful' Corby out of depression as clemency lifts spirits
The Canberra Times
Schapelle Corby is believed to be recovering from depression and bouts of psychosis that have affected her in jail. Kerobokan jail's doctor Agung Hartawan said yesterday that Corby was in good spirits following the news of her clemency.
Corby stages dramatic recoveryBigPond News
man whose love keeps Schapelle Corby saneNEWS.com.au
Corby case that divided a nationAdelaide Now

all 919 news articles »

The many faces of depression
Chicago Tribune
Sadness touches all of our lives at different times, but depression can have enormous depth and staying power. It's more than a passing bout of sadness or dejection, or feeling down in the dumps. It can leave you feeling continuously burdened and can ...
Has depression become a cliché?InjuryBoard.com

all 2 news articles »

The Masculine Mystique and Male Depression: Embracing Your Vocation of Destiny
Huffington Post (blog)
That was the year my father became overwhelmed with depression and tried to take his own life. My father was a writer with dreams of success, which to him meant being able to make a living and support his family. I began to understand what drove him ...

PsychCentral.com
Erratic Web Use Associated With Depression
ITProPortal
A study on the behaviour of university students online and its correlation with depression has highlighted that those with the illness tend to use the internet more erratically, and in many different ways compared to their non-depressed classmates.
Depression Linked With More Internet UsePsychCentral.com
High internet use linked to depression - researchHerald Sun
Depressed people act differently onlineMSN NZ News
Business Review Australia -Tech2
all 11 news articles »

Sarasota Herald-Tribune
Depression is a genuine illness
Sarasota Herald-Tribune
Depression is a common illness that affects one out of five people at one time or more during their lives. It's not the ordinary sadness that people feel when misfortune strikes. It's something that often strikes out of the blue and lasts for what ...

and more »

Contactmusic.com
Jason Derulo says Jordin Sparks kept him from sinking into depression ...
Fox News
Jason Derulo says girlfriend Jordin Sparks kept him from sinking into depression following a serious spine injury. And after four and a half months of being in a neck brace, Derulo said performing his new single “Undefeated” during the "American Idol" ...
Jason Derulo: Jordin Sparks Saved Me From DepressionContactmusic.com
Jason Derulo says Jordin Sparks helped him through neck fracture ordealMyFox Phoenix
Jason Derulo: Jordin saved meBelfast Telegraph

all 34 news articles »

Stuff.co.nz
Stay-at-home mums more depressed
Stuff.co.nz
According to a US poll by Gallup released last week, mothers who don't work outside the home were far more likely to be depressed, with 28 per cent reporting depression, compared with 17 per cent of working mothers, and also 17 per cent of working ...
How mothers who stay at home are LESS happy than those who work - and more ...Daily Mail
Stay At Home Moms Are Less Happy Than Working Moms -- StudyHollywood Life
Working Mothers Emotionally Stable Than Stay-At-Home MothersTopNews New Zealand
The Stir
all 8 news articles »

Google News